531541 — KOBO Biotech Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹92.92m
- IN₹1.48bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -245 | -210 | -192 | -152 | -55.5 |
Depreciation | |||||
Non-Cash Items | 144 | 145 | 108 | 1.34 | 0 |
Other Non-Cash Items | |||||
Changes in Working Capital | 248 | 151 | 164 | 1,042 | 23.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 209 | 145 | 137 | 938 | 8.75 |
Capital Expenditures | -0.036 | -0.027 | 0 | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | 251 | 0 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.036 | -0.027 | 0 | 251 | 0 |
Financing Cash Flow Items | -144 | -145 | -108 | -1.34 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -209 | -145 | -122 | -1,203 | -8.74 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.016 | -0.017 | 14.3 | -14.3 | 0.006 |